Nuvation Bio Financials
| NUVB Stock | USD 2.58 0.11 4.09% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0046 | 0.0066 |
|
| |||||
| Current Ratio | 33.85 | 44.1129 |
|
|
The financial analysis of Nuvation Bio is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Nuvation Bio includes many different criteria found on its balance sheet. For example, investors should never minimize Nuvation Bio's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Nuvation Bio's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Nuvation Bio.
Net Income |
|
With this module, you can analyze Nuvation financials for your investing period. You should be able to track the changes in Nuvation Bio individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Nuvation | Select Account or Indicator |
Understanding current and past Nuvation Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nuvation Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Nuvation Bio's assets may result in an increase in income on the income statement.
The data published in Nuvation Bio's official financial statements usually reflect Nuvation Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nuvation Bio. For example, before you start analyzing numbers published by Nuvation accountants, it's critical to develop an understanding of what Nuvation Bio's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Nuvation Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nuvation Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nuvation Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nuvation Bio. Please utilize our Beneish M Score to check the likelihood of Nuvation Bio's management manipulating its earnings.
Nuvation Bio Stock Summary
Nuvation Bio competes with Assembly Biosciences, Instil Bio, Achilles Therapeutics, NextCure, and CytomX Therapeutics. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US67080N1019 |
| CUSIP | 67080N101 698102100 |
| Location | California; U.S.A |
| Business Address | 1500 Broadway, New |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.nuvationbio.com |
| Phone | 332 208 6102 |
| Currency | USD - US Dollar |
You should never invest in Nuvation Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nuvation Stock, because this is throwing your money away. Analyzing the key information contained in Nuvation Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nuvation Bio Key Financial Ratios
Generally speaking, Nuvation Bio's financial ratios allow both analysts and investors to convert raw data from Nuvation Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Nuvation Bio over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nuvation Bio reports annually and quarterly.| Return On Equity | -0.12 | ||||
| EBITDA | (99.6 M) | ||||
| Net Income | (75.8 M) |
Nuvation Bio Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Tangible Assets | (24.1M) | (52.4M) | 746.0M | 655.1M | 753.3M | 791.0M | |
| Retained Earnings | (34.3K) | (76.0M) | (162.8M) | (267.0M) | (342.8M) | (325.7M) | |
| Accounts Payable | 2.0K | 2.2M | 3.9M | 2.1M | 2.2M | 1.9M | |
| Total Current Assets | 119.9K | 220.7M | 772.1M | 667.3M | 616.4M | 417.4M |
Nuvation Bio Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Nuvation Bio. It measures of how well Nuvation is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Nuvation Bio brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Nuvation had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Nuvation Bio has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 3.5K | 26.3M | 102.7M | (31.3M) | (58.5M) | (55.5M) | |
| Depreciation | 13.0 | 103K | 184K | 199K | 222K | 132.2K | |
| Capital Expenditures | 659.0 | 145K | 282K | 370K | 69K | 65.6K | |
| Net Income | (33.6K) | (41.7M) | (86.8M) | (104.2M) | (75.8M) | (79.6M) |
Nuvation Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nuvation Bio's current stock value. Our valuation model uses many indicators to compare Nuvation Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nuvation Bio competition to find correlations between indicators driving Nuvation Bio's intrinsic value. More Info.Nuvation Bio is regarded second in return on equity category among related companies. It is regarded third in return on asset category among related companies . At present, Nuvation Bio's Return On Equity is projected to increase slightly based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Nuvation Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nuvation Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nuvation Bio's earnings, one of the primary drivers of an investment's value.Nuvation Bio Systematic Risk
Nuvation Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nuvation Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Nuvation Bio correlated with the market. If Beta is less than 0 Nuvation Bio generally moves in the opposite direction as compared to the market. If Nuvation Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nuvation Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nuvation Bio is generally in the same direction as the market. If Beta > 1 Nuvation Bio moves generally in the same direction as, but more than the movement of the benchmark.
About Nuvation Bio Financials
What exactly are Nuvation Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Nuvation Bio's income statement, its balance sheet, and the statement of cash flows. Potential Nuvation Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Nuvation Bio investors may use each financial statement separately, they are all related. The changes in Nuvation Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nuvation Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Nuvation Bio Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Nuvation Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Nuvation has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Nuvation Bio's financials are consistent with your investment objective using the following steps:- Review Nuvation Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Nuvation Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Nuvation Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Nuvation Bio's stock is overvalued or undervalued.
Today, most investors in Nuvation Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nuvation Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nuvation Bio growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Nuvation Bio April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nuvation Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nuvation Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nuvation Bio based on widely used predictive technical indicators. In general, we focus on analyzing Nuvation Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nuvation Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.57 | |||
| Information Ratio | 0.1193 | |||
| Maximum Drawdown | 46.16 | |||
| Value At Risk | (6.50) | |||
| Potential Upside | 16.67 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Nuvation Stock analysis
When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Nuvation Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.35) | Return On Assets (0.1) | Return On Equity (0.12) |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.